XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

Rhea-AI Summary

XOMA Royalty (NASDAQ: XOMA), a biotech royalty aggregator, has announced its participation in the upcoming Jones Healthcare and Technology Innovation Conference. Chief Investment Officer Brad Sitko will deliver a presentation on Wednesday, April 9, 2025, at 10:30 AM PT.

The presentation will be accessible through a dedicated link and the investor relations section of XOMA's website. Interested parties can access the replay, which will remain available for 90 days following the event.

News Market Reaction – XOMA

+2.49%

+2.49% Session move

In the trading session that priced this news, XOMA gained 2.49%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and Technology Innovation Conference being held April 8-9, 2025.

Mr. Sitko’s presentation will take place on Wednesday, April 9, 2025, at 10:30 AM PT.  The presentation can be assessed by visiting https://bit.ly/4l7bz6m.

XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com.  A replay of each presentation will be available and archived on the site for 90 days after the event.

About XOMA Royalty Corporation
XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.  XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.  When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes.  The Company has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate).  For more information about the Company and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.

XOMA Investor Contact Juliane Snowden XOMA Royalty +1 646-438-9754 juliane.snowden@xoma.com

XOMA Media Contact Kathy Vincent KV Consulting & Management kathy@kathyvincent.com

FAQ

When is XOMA's presentation at the Jones Healthcare Conference 2025?

XOMA's presentation is scheduled for Wednesday, April 9, 2025, at 10:30 AM PT during the Jones Healthcare and Technology Innovation Conference.

How long will XOMA's conference presentation replay be available?

The presentation replay will be archived and available for 90 days after the event on XOMA's website.

Who will represent XOMA at the Jones Healthcare Conference 2025?

Brad Sitko, XOMA's Chief Investment Officer, will be the featured presenter at the conference.

Where can investors access XOMA's Jones Healthcare Conference presentation?

The presentation can be accessed through a dedicated link or through the investor relations section of XOMA's website at www.xoma.com.